BGMS (Bio Green Med Solution) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

What is Bio Green Med Solution LT-Debt-to-Total-Asset?

Bio Green Med Solution BGMS +20.88% 47 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates BGMS with a GF Score™ of 47/100 and a GF Value™ of $2.56 (Possible Value Trap). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bio Green Med Solution's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Bio Green Med Solution's long-term debt to total assets ratio declined from Mar. 2025 (0.00) to Mar. 2026 (0.00). It may suggest that Bio Green Med Solution is progressively becoming less dependent on debt to grow their business.

Bio Green Med Solution (NAS:BGMS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Bio Green Med Solution LT-Debt-to-Total-Asset Related Terms

Bio Green Med Solution LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Bio Green Med Solution's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Green Med Solution LT-Debt-to-Total-Asset Chart

Bio Green Med Solution Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

Bio Green Med Solution Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

47GF Score

Bio Green Med Solution Inc BGMS

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bio Green Med Solution LT-Debt-to-Total-Asset Calculation

Bio Green Med Solution's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	0.002	/	8.185
	=	0.00

Bio Green Med Solution's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	0	/	7.564
	=	0.00

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Bio Green Med Solution (BGMS) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bio Green Med Solution and its competitors.

Is Bio Green Med Solution's LT-Debt-to-Total-Asset too high?

Bio Green Med Solution's current LT-Debt-to-Total-Asset is 0.00. Overall, Bio Green Med Solution has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Bio Green Med Solution's LT-Debt-to-Total-Asset compare to GRI and PPCB?

Bio Green Med Solution's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Biotechnology company?

A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bio Green Med Solution and its competitors. Bio Green Med Solution's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bio Green Med Solution stock overvalued right now?

Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.56, compared to a current price of $1.10 — trading 57% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Bio Green Med Solution's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio Green Med Solution (BGMS) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued. The current stock price of $1.10 is trading 57% below its estimated GF Value™ of $2.56. GuruFocus considers Bio Green Med Solution to be Possible Value Trap.

Key valuation signals for BGMS:

LT-Debt-to-Total-Asset: 0.00
GF Value™: $2.56 vs. price of $1.10 (57% below fair value)
GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio Green Med Solution Business Description

Industry Healthcare Biotechnology

Comparable Companies GRI PPCB SPRC BIXT ACUT DCOY CLDI CDT CMND ONCO VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges BGMSP.PFD:USA

Address No. 8 Jalan Kerinchi, Avenue 5, Level 10, Tower 11, Kuala Lumpur, SGR, MYS, 59200

Website https://bgmsglobal.com

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.

47GF Score

Get the complete analysis for BGMS

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.10

Price

$2.56

GF Value

View BGMS Analysis

See LT-Debt-to-Total-Asset data for all stocks →